See more funds from Capita Financial Managers
See more funds in the Sterling Corporate Bond sector
See more funds managed by: Jan Luthman
Fund Overview |
|
|---|---|
| Unit Prices |
Buy: 146.62p
/ Sell: 140.76p
23/05/2012 |
| Standard Initial Charge | n/a |
| TQ Invest Discount | 0.00% |
| Initial Charge Through TQ Invest | n/a |
| Annual Management Charge | n/a |
| Total Expense Ratio | 1.12% |
| Fund size | £22,000,000 |
| Usable in ISA | No |
| Holding | Weighting |
|---|---|
| Glaxosmithkline Capital 5.25% Gtd Nts 19/12/33 Gbp1000 | 3.30% |
| Tesco 5.5% Nts 13/12/19 Gbp1000 | 2.00% |
| Reed Elsevier Inv 5.625% 05/10/2016 | 2.00% |
| British Telecommunications 3.50% Idx Lkd Nts 25/4/2025 Gbp(Var) | 1.80% |
| Ge Capital Uk Funding 5.125% Nts 24/05/23 Gbp1000 | 1.80% |
| Imperial Tobacco Finance 9% Gtd Nts 17/02/22 Gbp50000 | 1.80% |
| Roche Hldgs Inc 5.5% Mtn 04/03/15 Gbp5000 | 1.80% |
| Australia & New Zealand Bank Group 4.75% Nts 7/12/18 Gbp1000 | 1.70% |
| National Grid 6.125% Inst 15/04/14 Gbp50000 | 1.70% |
| Tesco 4% Idx Lkd Notes 8/9/16 Gbp(Var) | 1.60% |
| Sector | Weighting |
|---|
| Region | Weighting |
|---|---|
| Uk | 100.00% |
| Asset Type | Weighting |
|---|---|
| Uk Fixed Interest | 100.00% |
Data provided by 
The value of this investment and the income from it can go down as well as up. Past performance should not be regarded as a guide to the future. The investment described may not be suitable for all recipients and this factsheet does not constitute personalised investment advice. No liability is accepted for any loss arising from errors or omissions.